Keyphrases
Mouse Model
100%
Oligomeric
100%
Aged Persons
100%
Tauopathy
100%
Human tau
100%
Tau Oligomers
100%
Passive Immunity
100%
Monoclonal Antibody
66%
Aged Animals
50%
Aged Mice
33%
Late-onset
16%
Risk Factors
16%
Clinical Trials
16%
Therapeutic Approaches
16%
Serum IgE
16%
Disease Progression
16%
Biochemical Assay
16%
Disease Phenotype
16%
Cognitive Function
16%
Brain Tissue
16%
Intravenous Injection
16%
Disease Pathology
16%
Toxic Species
16%
Novel Object Recognition
16%
Oligomeric tau
16%
Y-maze
16%
Immunological Assay
16%
Model in Vitro
16%
Prion-like
16%
JNPL3
16%
Cognitive Phenotype
16%
HTau
16%
Tauopathy Model
16%
Neuroscience
Immunotherapy
100%
Oligomer
100%
Tauopathy
100%
Monoclonal Antibody
66%
In Vitro
16%
Cognitive Function
16%
Prion Protein
16%
Immunology and Microbiology
Mouse Model
100%
Immunotherapy
100%
Monoclonal Antibody
80%
Conformation
20%
Brain Tissue
20%
Cognition
20%
Novel Object Recognition Test
20%
Prion Protein
20%
Biochemistry, Genetics and Molecular Biology
Mouse Model
100%
Tau
100%
Monoclonal Antibody
30%
Clinical Trial
7%
Conformation
7%
Cognition
7%
Novel Object Recognition Test
7%
Prion Protein
7%